Webinar: International Health Policy Forum for the Elimination of HTLV. Meeting Report
MetadataShow full item record
Human T cell lymphotropic virus (HTLV) infection affects mainly vulnerable population groups: people living in poverty in areas with very low human development indexes, sex workers, men who have sex with men, people who inject drugs, and epidemiologically closed and semi-closed population groups including traditional populations and indigenous people. This virus and its consequences have been neglected for decades, despite the high morbidity and mortality attributable to HTLV infection. Public health policies for HTLV-1/2 are considered scarce in the Region of the Americas and are usually limited to screening of blood donors. Scaling up HTLV-1/2 testing should be prioritized, and counseling of those living with HTLV-1 is an opportunity to prevent transmission. Testing pregnant women, followed by avoidance of or limited breastfeeding, should be a priority, and targeted testing for those at high risk of infection should be considered. Lack of awareness about HTLV is a major challenge, and PAHO/WHO engagement is crucial to surpass this obstacle. Inclusion of HTLV in existing programs, such as STI and maternal health, and programs focused on elimination of infectious diseases and neglected infections, was identified as an opportunity to facilitate implementation of health policies relating to HTLV-1/2 in the Region. Investment in research is needed to close gaps in knowledge and to develop cost-effective policies and tools supporting the advancement of successful public health responses such as low-cost point of care tests for HTLV-1/2 diagnosis. HTLV infection also has negative impact on the outcomes of co-infections that are common in the Region, including tuberculosis, strongyloidiasis, STIs, and mycosis. Genetic, environmental, and sociocultural aspects may influence HTLV-1 clustering or disease outcomes in the Region. Familial aggregation is also important and should be considered when evaluating the impact of HTLV-1 infections and designing policies to combat this virus. HTLV-2 is the predominant virus type among Amerindians. Successful policies to control this infection should rely on a combined approach to overcoming linguistic, cultural, and geographic barriers. This report highlights some of the main interventions available for the prevention and control of human T cell lymphotropic virus (HTLV) infection and its consequences and summarizes national and institutional experiences, discussions, successes, and challenges associated with the implementation of public health policies toward the elimination of HTLV infection. These topics were presented at the webinar “HTLV World Day 2021: International health policy forum for the elimination of HTLV – Advancing HTLV health policies around the world.”Webinar HTLV World Day 2021: International health policy forum for the elimination of HTLV Advancing HTLV health policies around the world (November 10, 2021 - 8am to 3pm (Brasília, DF -GTM-3)).
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Pan American Health Organization; Noncommunicable Diseases and Mental Health (NMH) (Washington, D.C., PAHO, 2021-12-01)Consumption of trans-fatty acids (TFAs) is a major cause of global morbidity and mortality. It has no known health benefits and is a major contributor to heart disease worldwide. It is estimated that TFAs cause about 260,000 ...
VIII Ad Hoc Meeting of PAHO’s Technical Advisory Group (TAG) On Vaccine-Preventable Diseases: Technical Briefing on the Multi-Country Monkeypox Outbreak, 31 May 2022 (virtual) Pan American Health Organization; Family, Health Promotion and Life Course (FPL) (Washington, D.C., PAHO, 2022-06-10)Monkeypox virus is an orthopoxvirus that causes a disease with symptoms similar, but less severe, to smallpox. While smallpox was eradicated in 1980, monkeypox continues to occur in countries of Central and West Africa. ...
VIII Ad Hoc Meeting of PAHO’s Technical Advisory Group (TAG) on Vaccine-Preventable Diseases. Technical Briefing on the Multi-Country Monkeypox Outbreak: Recommendations on Monkeypox Vaccines and Vaccination Pan American Health Organization; Family, Health Promotion and Life Course (FPL) (Washington, D.C., PAHO, 2022-06-17)Monkeypox virus is an orthopoxvirus that causes a disease with symptoms similar, but less severe, to smallpox. While smallpox was eradicated in 1980, monkeypox continues to occur in countries of Central and West Africa. ...